Low Rate of CMV End-Organ Disease in HIV-Infected Patients Despite Low CD4+ Cell Counts and CMV Viremia: Results of ACTG Protocol A5030

PURPOSE: To describe cytomegalovirus (CMV) end-organ disease (EOD) rate in AIDS patients with low CD4+ cell count despite HAART who were enrolled in a randomized, placebo-controlled trial of preemptive valganciclovir (VGCV) to prevent CMV EOD in those with CMV viremia. METHODS: Subjects (N = 338) we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wohl, D. A., Kendall, M. A., Andersen, J., Crumpacker, C., Spector, S. A., Feinberg, J., Alston-Smith, B., Owens, S., Chafey, S., Marco, M., Maxwell, S., Lurain, N., Jabs, D., Benson, C., Keiser, P., Jacobson, M. A.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2754189/
https://ncbi.nlm.nih.gov/pubmed/19632953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hct1003-143
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars